Login     Register  
    Home  |   Your Profile  |   Search  |   About Us  |   Disclaimer  |   Pricing  |   Participating on CanBiotech
Can Biotech - BioPharma Portal and B2B Marketplace 4th Content Marketing for Life Sciences Conference
Site Search:
    Home Open Innovation Patient Engagement Engaged Thinking Directory Events News Careers
 Event Advertisers   Show all: Event Advertisers

Click here to subscribe to Can Biotech Newsletters

 My Links   Show all: My Links

 CanBiotech News   Show all: CanBiotech News

 Investor: Alliances   Show all: Investor: Alliances

 Biopharma News in Asia   Show all: Biopharma News in Asia

 Innovation Blogs and News   Show all: Innovation Blogs and News
Patient Research Priorities
October 2015
Is there a disparity between what patients think are research priorities and the focus of academic/industry studies? Patients become experts in regard to disease and health management; their research priorities can often differ from those of academic/industry based researchers. 

atient Engagment/Engaged Thinking Social Community Launched
September 18 2015

Visit CanBiotech's new patient engagement and engaged thinking community. Participate in the development of the concept of engaged thinking in health innovation and the identification of "lead patients".


Low cost, tabletop plasma cleaners for nanoscale surface cleaning, surface activation, and surface chemistry modification of glass and semiconductor substrates, polymers, and biomaterials. Our instruments have been cited in over 2600 publications in research areas of materials science, microfluidics, biomedical applications, spectroscopy, and microscopy.

Listening to Patients
September 2015

In its own move to patient centricity, Sanofi seeks to use practical cases internally to illustrate to staff how things can change toward patient centricity.

Fostering Behavior Change for Better Health

Using design thinking, researchers developed five distinct patient segments and created journey maps to chart the experiences of patients from each of these segments from diagnosis to long-term treatment adherence in the context of HIV management.

Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes
September 2015

The collaboration will pair Sanofi’s leadership in diabetes treatments and devices with Google’s expertise in analytics, miniaturized electronics and low power chip design. The companies will explore how to improve diabetes care by developing new tools that bring together many of the previously siloed pieces of diabetes management and enable new kinds of interventions. This includes health indicators such as blood glucose and hemoglobin A1c levels, patient-reported information, medication regimens and sensor devices.


The Lilly COI API and TrialReach: A Story of Innovation
August 2015

A vision for inclusive and participatory clinical knowledge generation, with particpation by all including patients in the clinical research ecosystem. Participatory is at the core of open innovation at Lilly.

Patient Engagement and Cultural Competence
July 2015

Should the pharmaceutical industry consider cultural competence a driver for more holistic patient engagement? Care providers and health care organizations are seeking to align patient engagement and cultural competency to better understand disease management and compliance issues.

Pfizer's Global Innovation Network
June 2015

In this webinar, Pfizer's Daniel Seewald explores the keys to success in creating a global network of innovation “champions”.

An Interview with Novartis
June 2015

In this interview, the CEO of Swiss pharmaceutical company Novartis, Joseph Jimenez, discusses how digitization is driving innovation, and why Novartis is shifting to an outcomes-based approach for patient treatments.

Pharma Behind Other Industries in Customer Engagement

Expanded Patient Role
June 2015

Patient engagement can be traced across the drug-development pipeline including the impact of recent policy initiatives, and prospects moving forward.

Universal Medica Group and its’ partners are proud to announce the opening of registrations for the 6th edition of Innovation Days, on October 5th and 6th, at the Cité Universaire of Paris.

Exploring open innovation with a patient focus in drug discovery: an evolving paradigm of patient engagement
It is suggested in this article that patient engagement should occur further upstream during the drug discovery stage. ‘Lead patients’, namely those patients who are proactive with respect to their health, possess knowledge of their disease and resulting symptoms. They are also well informed about the conventional as well as non-conventional treatments for disease management; and so can provide a nuanced perspective to drug design.
Read More:

Continuing Reading More Innovation News and Blogs...

Using the Site Privacy & Security Statement Advertise with us Directory Guide & Access Policy Event Postings CanBiotech Newsletters

© 2000-2015 CanBiotech™ Inc.